Understand the science, and the value, in treating diabetes

It’s a daunting challenge: stem a global epidemic impacting 415 million adults.

And with broader populations, expanding treatment options, and new digital support tools, understanding the science and the value in treating diabetes becomes even more critical to understand.

Faster, more cost effective evidence generation approaches are helping teams, today. Access to global real-world insights can help optimize your protocol, while also providing insights to identify the optimal sites to locate much needed study participants. Advances in economic modelling help predict long term health outcomes in both type 1 and 2 diabetes. And marketers are tapping into more granular market insights.

IQVIA’s enterprise diabetes portfolio can:

  • Enhance your development efforts with advanced and predictive analytics for early signal detection or issue avoidance, which helps de-risk your pipeline.
  • Support your clinical and sales teams with an unparalleled source of diabetes enriched EMR and longitudinal prescription data.
  • Couple real-world data with our Core Diabetes Model, the most widely used economic model in the healthcare industry, to accurately predict health outcomes and costs in type 1 and type 2 diabetes.
  • Improve commercial outcomes by using real-world data to influence sales force effectiveness, targeting, call activity and brand performance.

Learn how we can help you define value and increase efficiency in your diabetes program.

Flexible solutions for Emerging Biopharma Companies
From defining the plan for your asset, to trial implementation, through launch and commercialization, IQVIA can help you find your path to success.